{"schema_version":"secwatch.filing_event.v1","accession":"0000950103-24-011822","form_type":"8-K","ticker":"ANIP","cik":"0001023024","company_name":"ANI PHARMACEUTICALS INC","filed_at":"2024-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.919009+00:00","generated_at":"2026-05-31T11:33:03.033055+00:00","sec_items":["8.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"ANI Pharma proposes $250M convertible notes due 2029; to repay term loan","bullets":["Offering $250M in Convertible Senior Notes due Sept 1, 2029; underwriters option for additional $37.5M.","Proceeds used to repay existing senior secured term loan; new $325M delayed draw term loan and $75M revolver planned.","Capped call transactions expected to reduce dilution on conversion of notes.","Interest rate, conversion rate, and other terms to be set at pricing.","Notes unsecured; redemption at ANI's option after Sept 1, 2027 under certain conditions."],"urls":{"canonical":"https://secwatch.observer/filing/0000950103-24-011822","json":"https://secwatch.observer/filing/0000950103-24-011822.json","markdown":"https://secwatch.observer/filing/0000950103-24-011822.md","text":"https://secwatch.observer/filing/0000950103-24-011822.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1023024/000095010324011822/0000950103-24-011822-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1023024/000095010324011822/dp216241_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T11:33:03.033055+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}